NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

醫療的人工智慧 (AI)的全球市場:各用途,各終端用戶的市場調查,預測(∼2025年),COVID-19的累積性的影響

Artificial Intelligence in Medicine Market Research Report by Application, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 989883
出版日期 內容資訊 英文 186 Pages
商品交期: 最快1-2個工作天內
價格
醫療的人工智慧 (AI)的全球市場:各用途,各終端用戶的市場調查,預測(∼2025年),COVID-19的累積性的影響 Artificial Intelligence in Medicine Market Research Report by Application, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 186 Pages
簡介

全球醫療的人工智慧 (AI的)市場規模,預計從2020年的19億4,681萬美元,至2025年末成長為74億9,468萬美元。

COVID-19是影響幾乎全部產業的無與倫比的世界公共衛生緊急事件,在預測期間內預計帶給產業的成長長期性的影響。目前進行的調查擴大了框架,以確保包括潛在的COVID-19問題和發展途徑。 本報告提供有關COVID-19的見解,其中考慮了消費者行為和需求的變化,購買方式,供應鏈的新路由,當前市場力量的動態以及政府的重要介入等COVID-19對市場的影響相關洞察。更新的調查,考慮市場上COVID-19的影響,提供洞察,分析,估計,及預測。

本報告提供針對醫療的人工智慧 (AI的)世界市場調查,市場概要,市場成長要素及阻礙因素分析,市場機會,COVID-19的影響,各用途、終端用戶、地區的市場規模的變化與預測,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和涵蓋範圍
  • 為了調查被考慮的年
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查手法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 計劃:調查計劃的作成
    • 實行:調查的實施
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查成果

第3章 摘要整理

  • 市場預測
  • 用途預測
  • 終端用戶預測
  • 地區預測
  • 其他競爭公司預測

第4章 市場概要

  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特的五力分析
    • 新加入業者的威脅
    • 替代品的威脅
    • 客戶談判力
    • 供給企業談判力
    • 產業的競爭

第6章 各用途

  • 病的診斷與鑑定
  • 患者照護
  • 研究和藥物的開發

第7章 各終端用戶

  • ACOS和MCOS
  • 患者
  • 付款人
  • 製藥及生物科技企業
  • 供應商

第8章 南北美洲

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第10章 歐洲,中東、非洲

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第11章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併和收購
    • 協定,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 獎,獎勵,擴大

第12章 企業的實用性簡介

  • Atomwise, Inc.
  • BERG, LLC
  • BioXcel Corporation
  • Cyrcadia Health, Inc.
  • Enlitic Inc.
  • General Vision
  • Google LLC
  • IBM Watson Health
  • Insilico Medicine, Inc.
  • Intel
  • Microsoft Corporation
  • NVIDI
  • NVIDIA Corporation
  • Verge Analytics, Inc.
  • Welltok, Inc.
  • Zebra Medical Vision Ltd.

第13章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-4330CC794AAE

The Global Artificial Intelligence in Medicine Market size was estimated at USD 1,946.80 Million in 2020 and expected to reach USD 2,558.96 Million in 2021, at a Compound Annual Growth Rate (CAGR) 31.78% to reach USD 10,196.95 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Artificial Intelligence in Medicine to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Application, the Artificial Intelligence in Medicine Market was studied across Disease Diagnosis & Identification, Patient Care, and Research & Drug Invention.

Based on End User, the Artificial Intelligence in Medicine Market was studied across ACOS & MCOS, Patients, Payers, Pharmaceutical & Biotechnology Companies, and Providers.

Based on Geography, the Artificial Intelligence in Medicine Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Artificial Intelligence in Medicine Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Artificial Intelligence in Medicine Market, including Atomwise, Inc., BERG, LLC, BioXcel Corporation, Cyrcadia Health, Inc., Enlitic Inc., General Vision, Google LLC, IBM Watson Health, Insilico Medicine, Inc., Intel, Microsoft Corporation, NVIDI, NVIDIA Corporation, Verge Analytics, Inc., Welltok, Inc., and Zebra Medical Vision Ltd..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Artificial Intelligence in Medicine Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Artificial Intelligence in Medicine Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Artificial Intelligence in Medicine Market?
  • 4. What is the competitive strategic window for opportunities in the Global Artificial Intelligence in Medicine Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Artificial Intelligence in Medicine Market?
  • 6. What is the market share of the leading vendors in the Global Artificial Intelligence in Medicine Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Artificial Intelligence in Medicine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Application Outlook
  • 3.4. End User Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of cross-industry partnerships and collaborations
      • 5.1.1.2. Increase in need to reduce healthcare costs
      • 5.1.1.3. Increased emphasis on adoption of digital transformation practices to realize cost savings
    • 5.1.2. Restraints
      • 5.1.2.1. Unavailability of skilled professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising focus on developing human-aware artificial intelligence systems
      • 5.1.3.2. Increase in the consumption of artificial intelligence in medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Growing concerns regarding data privacy
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Artificial Intelligence in Medicine Market, by Application

  • 6.1. Introduction
  • 6.2. Disease Diagnosis & Identification
  • 6.3. Patient Care
  • 6.4. Research & Drug Invention

7. Artificial Intelligence in Medicine Market, by End User

  • 7.1. Introduction
  • 7.2. ACOS & MCOS
  • 7.3. Patients
  • 7.4. Payers
  • 7.5. Pharmaceutical & Biotechnology Companies
  • 7.6. Providers

8. Americas Artificial Intelligence in Medicine Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States
    • 8.6.1. California
    • 8.6.2. Florida
    • 8.6.3. Illinois
    • 8.6.4. New York
    • 8.6.5. Ohio
    • 8.6.6. Pennsylvania
    • 8.6.7. Texas

9. Asia-Pacific Artificial Intelligence in Medicine Market

  • 9.1. Introduction
  • 9.2. China
  • 9.3. India
  • 9.4. Indonesia
  • 9.5. Japan
  • 9.6. Malaysia
  • 9.7. Philippines
  • 9.8. South Korea
  • 9.9. Thailand

10. Europe, Middle East & Africa Artificial Intelligence in Medicine Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Quadrant
  • 11.4. Market Share Analysis, By Company
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Atomwise, Inc.
  • 12.2. BERG, LLC
  • 12.3. BioXcel Corporation
  • 12.4. Cyrcadia Health, Inc.
  • 12.5. Enlitic Inc.
  • 12.6. General Vision
  • 12.7. Google LLC
  • 12.8. IBM Watson Health
  • 12.9. Insilico Medicine, Inc.
  • 12.10. Intel
  • 12.11. Microsoft Corporation
  • 12.12. NVIDI
  • 12.13. NVIDIA Corporation
  • 12.14. Verge Analytics, Inc.
  • 12.15. Welltok, Inc.
  • 12.16. Zebra Medical Vision Ltd.

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
  • 13.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET: MARKET DYNAMICS
  • FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS & IDENTIFICATION, 2018-2026 (USD MILLION)
  • FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS & IDENTIFICATION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PATIENT CARE, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PATIENT CARE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY RESEARCH & DRUG INVENTION, 2018-2026 (USD MILLION)
  • FIGURE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY RESEARCH & DRUG INVENTION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2020 VS 2026 (%)
  • FIGURE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
  • FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2026
  • FIGURE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY ACOS & MCOS, 2018-2026 (USD MILLION)
  • FIGURE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY ACOS & MCOS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PATIENTS, 2018-2026 (USD MILLION)
  • FIGURE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PATIENTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PAYERS, 2018-2026 (USD MILLION)
  • FIGURE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PAYERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2026 (USD MILLION)
  • FIGURE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PROVIDERS, 2018-2026 (USD MILLION)
  • FIGURE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PROVIDERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 29. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 30. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 32. ARGENTINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 33. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 34. CANADA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 35. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 36. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 37. CALIFORNIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 38. FLORIDA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 39. ILLINOIS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 40. NEW YORK ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 41. OHIO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 42. PENNSYLVANIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 43. TEXAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 44. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 45. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 47. CHINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. INDIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. INDONESIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. JAPAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. MALAYSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. PHILIPPINES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. THAILAND ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 56. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 57. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 58. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. ITALY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. NETHERLANDS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. QATAR ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. RUSSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 64. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 65. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 66. SPAIN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 68. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 69. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET: FPNV POSITIONING MATRIX
  • FIGURE 70. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 71. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 72. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY DISEASE DIAGNOSIS & IDENTIFICATION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PATIENT CARE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY RESEARCH & DRUG INVENTION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY ACOS & MCOS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PATIENTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PAYERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY PROVIDERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. AMERICAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. ARGENTINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. ARGENTINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. BRAZIL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. CANADA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. CANADA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. MEXICO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. UNITED STATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. CALIFORNIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. CALIFORNIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. FLORIDA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. FLORIDA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. ILLINOIS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. ILLINOIS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. NEW YORK ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. NEW YORK ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. OHIO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. OHIO ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. PENNSYLVANIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. PENNSYLVANIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. TEXAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. TEXAS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. CHINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. CHINA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. INDIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. INDIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. INDONESIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. INDONESIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. JAPAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. JAPAN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. MALAYSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. MALAYSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. PHILIPPINES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. PHILIPPINES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. THAILAND ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. THAILAND ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. FRANCE ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. GERMANY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. ITALY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. ITALY ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. NETHERLANDS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. NETHERLANDS ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. QATAR ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. QATAR ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. RUSSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. RUSSIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. SPAIN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. SPAIN ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET: SCORES
  • TABLE 86. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET: BUSINESS STRATEGY
  • TABLE 87. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET: PRODUCT SATISFACTION
  • TABLE 88. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET: RANKING
  • TABLE 89. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 90. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET: SHARE, BY COMPANY, 2020
  • TABLE 91. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET: MERGER & ACQUISITION
  • TABLE 92. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 93. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 94. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET: INVESTMENT & FUNDING
  • TABLE 95. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 96. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET: LICENSE & PRICING
  • TABLE 97. GLOBAL ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET: CONTACT DETAILS